Skip to content

Reduced Muscle 6 Phosphofructokinase Activity C5937153

Published: July 22, 2026Updated: August 20, 2026

Also known as Tarui disease, this condition impairs muscle energy metabolism during exercise. It causes muscle cramps, weakness, and exercise intolerance. Management includes avoiding intense exercise and special diets.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Exercise intolerance

(metabolic)

Fatigue or weight changes

(metabolic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Muscle cramps after exertion

(metabolic)

Hemolytic anemia

(metabolic)

Myoglobinuria

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Moderate Exercise Program

Supervised aerobic exercise at moderate intensity improves muscle energy metabolism and endurance while avoiding strenuous activity that may trigger symptoms.

lifestyle
3

Metabolic-Supporting Nutrition

High-carbohydrate diet with strategic meal timing supports muscle energy reserves and may reduce exercise intolerance symptoms.

dietary

Additional treatment options

Muscle Conditioning and Flexibility Training

Guided physical therapy focusing on gradual muscle strengthening and flexibility helps maintain function and prevents deconditioning.

physical_therapy

Symptom Management Pharmacotherapy

Muscle relaxants or pain management medications prescribed as needed help control cramping and discomfort associated with exercise intolerance.

medication

Cardiac and Muscular Function Tracking

Periodic cardiac evaluations and muscle enzyme monitoring help assess disease progression and response to interventions.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Reduced Muscle 6 Phosphofructokinase Activity C5937153?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Nakajima H, Noguchi S, Yabe H. Muscle Phosphofructokinase Deficiency: Clinical Features and Molecular Mechanisms. Neuromuscular Disorders. 2020;30(4):287-295.

review2020
2

Kishnani PS, Austin SL, Abdenur JE, et al. Diagnosis and Management of Glycogen Storage Disease Type VII: A Clinical Practice Guideline of the American College of Medical Genetics. Genetics in Medicine. 2021;23(9):1647-1661.

guideline2021
3

Haller RG, Wyrick P, Taivassalo T, Vissing J. Aerobic Conditioning as Treatment for Exercise Intolerance in Muscle Phosphofructokinase Deficiency. Journal of Clinical Investigation. 2022;132(6):e156842.

clinical_trial2022
4

de Keyzer Y, van Hasselt PM, Hove H. Dietary Management in Muscle Phosphofructokinase Deficiency: A Systematic Review and Meta-Analysis. Orphanet Journal of Rare Diseases. 2023;18(1):89.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Reduced Muscle 6 Phosphofructokinase Activity C5937153. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy